283 results on '"Olman, Mitchell A."'
Search Results
102. Glutathione regulates transforming growth factor-β-stimulated collagen production in fibroblasts
103. The Pattern of Enhancement of Src Kinase Activity on Platelet-derived Growth Factor Stimulation of Glioblastoma Cells Is Affected by the Integrin Engaged
104. Transforming growth factor-β induces fibrosis in immune cell-depleted lungs
105. Modulating the Fibrinolytic System of Peripheral Blood Mononuclear Cells with Adenovirus
106. Attachment of primary neonatal rat astrocytes to vitronectin is mediated by integrins αvβ5 and α8β1: modulation by the type 1 plasminogen activator inhibitor
107. Facile Purification of Fibrinogen Fragments Using a Computer-Based Model with General Applicability to the Generation of Salt Gradients
108. Pulmonary Arterial Hypertension
109. Macrophage migration inhibitory factor is required for recruitment of scar‐associated macrophages during liver fibrosis
110. Urokinase receptor mediates lung fibroblast attachment and migration toward provisional matrix proteins through interaction with multiple integrins.
111. Pulmonary Vascular Steal in Chronic Thromboembolic Pulmonary Hypertension
112. Gluthatione regulates transforming growth factor-β-stimulated collagen production in fibroblasts.
113. Transforming growth factor-$beta; induces fibrosis in immune cell-depleted lungs.
114. Effect of lactic acidosis on canine hemodynamics and left ventricular function.
115. ACTIVATED INTESTINAL MUSCLE CELLS PROMOTE PREADIPOCYTE MIGRATION: A NOVEL MECHANISM OF CREEPING FAT FORMATION IN CROHN'S DISEASE.
116. Additional file 3 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
117. Additional file 5 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
118. Additional file 4 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
119. Additional file 6 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
120. Additional file 7 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
121. Additional file 8 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
122. Additional file 3 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
123. Additional file 6 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
124. Additional file 7 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
125. Additional file 1 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
126. Additional file 2 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
127. Additional file 1 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
128. Additional file 4 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
129. Additional file 2 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
130. Rationale for Anticoagulant Therapy of Pulmonary Fibrosis.
131. A Placebo-controlled Randomized Trial of Warfarin In Idiopathic Pulmonary Fibrosis: A Hidden Subgroup?
132. Warfarin in Idiopathic Pulmonary Fibrosis: Friend or Foe, Is It a Matter of Genes and Heparin?
133. Is Warfarin the Right Anticoagulant in Idiopathic Pulmonary Fibrosis?
134. Adenovirally mediated expression of urokinase receptor binding site on integrin alpha-chain blocks adhesion and migration of human lung fibroblasts.
135. Adenovirally Mediated Expression of Urokinase Receptor Binding Site on Integrin α-Chain Clocks Adhesion and Migration of Human Lung Fibroblasts.
136. Warfarin in idiopathic pulmonary fibrosis: friend or foe, is it a matter of genes and heparin? : a reply to Tzouvelekis.
137. The Pattern of Enhancement of Src Kinase Activity on Platelet-derived Growth Factor Stimulation of Glioblastoma Cells Is Affected by the Integrin Engaged.
138. 22. Interrogating the gut-lung axis during chronic-binge ethanol exposure in mice.
139. TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice.
140. Urokinase-type Plasminogen Activator Receptor (uPAR) Ligation Induces a Raft-localized Integrin Signaling Switch That Mediates the Hypermotile Phenotype of Fibrotic Fibroblasts.
141. Focal Adhesion Kinase (FAK)-related Non-kinase Inhibits Myofibroblast Differentiation through Differential MAPK Activation in a FAK-dependent Manner.
142. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury.
143. Nocturnal Hypoxemia Is Associated with Sarcopenia in Patients with Chronic Obstructive Pulmonary Disease.
144. TRPV4 Regulates the Macrophage Metabolic Response to Limit Sepsis-induced Lung Injury.
145. A novel mechanoeffector role of fibroblast S100A4 in myofibroblast transdifferentiation and fibrosis.
146. TRP Channels in Pulmonary Fibrosis: Variety Is a Spice of Life.
147. Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease.
148. Stretching the Function of Innate Immune Cells.
149. RSV infection potentiates TRPV 1 -mediated calcium transport in bronchial epithelium of asthmatic children.
150. The Role of TRPV4 in Regulating Innate Immune Cell Function in Lung Inflammation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.